Tennessee bills · 114th Regular Session (2025-2026)
Tennessee HB 2457
TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Harris (Democratic)
Summary
No official summary is available for this bill.
Latest action(Mar 3, 2026): Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Mar 3, 2026 · House
Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee - Feb 25, 2026 · House
Placed on s/c cal Tenncare Subcommittee for 3/3/2026 - Feb 5, 2026 · House
P2C, ref. to Insurance Committee - Feb 5, 2026 · House
Assigned to s/c Tenncare Subcommittee - Feb 4, 2026 · House
Intro., P1C. - Feb 4, 2026 · House
Sponsor change. - Feb 3, 2026 · House
Filed for introduction